Studies are intended for scientific research and therapy optimisation. Since not only the medical success of proton therapy, but also the compatibility and the subsequent quality of life of patients is very important to us, all data collected during the treatment and the further course of the disease at the WPE are documented and evaluated.
The results obtained in this way will make it possible to more successfully assess the risks and benefits of proton therapy in the future. Based on this data, new treatment standards can be established and future study designs can be developed.
Currently, there is a registry study for adults and one for children. With an increasing number of patients, future studies relating to the base data will follow. Every clinical trial must be submitted for approval by an ethics committee and sometimes even by a federal agency. Only when the supervisory body expresses no concern about the clinical trial, can it be conducted.